HeartSciences (HSCS) Total Debt (2022 - 2026)

HeartSciences (HSCS) reported Total Debt of $421564.0 for Q1 2026, up 752.16% quarter-over-quarter from $49470.0 in Q4 2024.

HeartSciences (HSCS) Total Debt (2022 - 2026) Analysis & Trends

HeartSciences has reported Total Debt for 4 years, with the latest figure at $421564.0 in Q1 2026.

For the quarter ending Q1 2026, Total Debt changed N/A year-over-year to $421564.0; the trailing twelve-month figure through Jan 2026 stood at $421564.0 (changed N/A YoY), and the FY2023 full-year result was $500000.0, down 88.74% from the prior year.
Total Debt for Q1 2026 stood at $421564.0, up from $49470.0 in the prior quarter.
The five-year high for Total Debt was $4.4 million in Q2 2022, with the low at $49470.0 in Q4 2024.
Historically, Total Debt has averaged $1.1 million across 4 years, with a median of $500000.0 in 2023.
Annual changes were most pronounced in 2023 — Total Debt plunged 88.74% — and 2024, when it changed 0.0%.
HeartSciences' Total Debt stood at $1.0 million in 2022, then slumped by 50.0% to $500000.0 in 2023, then slumped by 90.11% to $49470.0 in 2024, then surged by 752.16% to $421564.0 in 2026.
The last three Total Debt figures came in at $421564.0 (Q1 2026), $49470.0 (Q4 2024), and $500000.0 (Q3 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	34.05 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	14.72 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	28.07 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	11.03 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	598.50 Mn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	9.48 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	10.13 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	1.93 Bn
10	HeartSciences	3.89 Mn	492,884.20	-	421,564.00

Download Data